Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules

Hallaji,M , Allahyari,M , Fard-Esfahani,P and Fayaz,S . (2024). Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules. (e739550). Iranian Biomedical Journal, 0(0), e739550 doi: 10.61882/ibj.5240

Hallaji,M , , Allahyari,M , , Fard-Esfahani,P , and Fayaz,S . "Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules" .e739550 , Iranian Biomedical Journal, 0, 0, 2024, e739550. doi: 10.61882/ibj.5240

Hallaji M, Allahyari M, Fard-Esfahani P, Fayaz S. (2024). 'Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules', Iranian Biomedical Journal, 0(0), e739550. doi: 10.61882/ibj.5240

M Hallaji, M Allahyari, P Fard-Esfahani and S Fayaz, "Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules," Iranian Biomedical Journal, 0 0 (2024): e739550, doi: 10.61882/ibj.5240

Hallaji M, Allahyari M, Fard-Esfahani P, Fayaz S. Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules. Iranian Biomedical Journal. 2024;0(0):e739550. doi: 10.61882/ibj.5240